As of 2024-12-12, the Relative Valuation of TherapeuticsMD Inc (TXMD) is (0.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.25 USD, the upside of TherapeuticsMD Inc based on Relative Valuation is -165.0%.
The range of the Relative Valuation is (0.34) - (1.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 1.1x - 4.3x | 2.7x |
| Forward P/E multiples | 1.2x - 4.7x | 3.0x |
| Fair Price | (0.34) - (1.23) | (0.81) |
| Upside | -127.1% - -198.0% | -165.0% |
| Date | P/E |
| 2024-12-10 | -4.45 |
| 2024-12-09 | -4.52 |
| 2024-12-06 | -4.28 |
| 2024-12-05 | -4.38 |
| 2024-12-04 | -4.59 |
| 2024-12-03 | -4.68 |
| 2024-12-02 | -4.76 |
| 2024-11-29 | -4.94 |
| 2024-11-27 | -4.90 |
| 2024-11-26 | -4.87 |
| 2024-11-25 | -4.83 |
| 2024-11-22 | -4.76 |
| 2024-11-21 | -4.62 |
| 2024-11-20 | -4.66 |
| 2024-11-19 | -4.52 |
| 2024-11-18 | -4.49 |
| 2024-11-15 | -4.87 |
| 2024-11-14 | -5.08 |
| 2024-11-13 | -5.21 |
| 2024-11-12 | -5.22 |
| 2024-11-11 | -5.29 |
| 2024-11-08 | -5.29 |
| 2024-11-07 | -5.29 |
| 2024-11-06 | -5.35 |
| 2024-11-05 | -5.35 |
| 2024-11-04 | -5.39 |
| 2024-11-01 | -5.39 |
| 2024-10-31 | -5.39 |
| 2024-10-30 | -5.39 |
| 2024-10-29 | -5.46 |
| 2024-10-28 | -5.44 |
| 2024-10-25 | -5.53 |
| 2024-10-24 | -5.49 |
| 2024-10-23 | -5.48 |
| 2024-10-22 | -5.49 |
| 2024-10-21 | -5.48 |
| 2024-10-18 | -5.56 |
| 2024-10-17 | -5.49 |
| 2024-10-16 | -5.49 |
| 2024-10-15 | -5.31 |
| 2024-10-14 | -5.29 |
| 2024-10-11 | -5.49 |
| 2024-10-10 | -5.49 |
| 2024-10-09 | -5.49 |
| 2024-10-08 | -5.63 |
| 2024-10-07 | -5.77 |
| 2024-10-04 | -5.71 |
| 2024-10-03 | -5.56 |
| 2024-10-02 | -5.74 |
| 2024-10-01 | -5.70 |